Zobrazeno 1 - 10 of 242 pro vyhledávání: '"Welters C"'
1
Editorial & Opinion
Oligonucleotide library screening for identification of virus-specific T-cell receptors.
Autor: Welters ML; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Stadler S; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Anastasopoulou V; Charité - Universitätsmedizin Berlin, Institute of Immunology, Berlin, Germany., Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Leisegang M; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Charité - Universitätsmedizin Berlin, Institute of Immunology, Berlin, Germany.; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, Illinois, USA., Kammertöns T; Charité - Universitätsmedizin Berlin, Institute of Immunology, Berlin, Germany., Welters C; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Hansmann L; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Publikováno v: European journal of immunology [Eur J Immunol] 2024 Jun; Vol. 54 (6), pp. e2350908. Date of Electronic Publication: 2024 Mar 19.
Zobrazit plný text záznamu
2
Akademický článek
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
Autor: Ben Hamza A; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Welters C; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Stadler S; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium, Partner Site Berlin, and German Cancer Research Center, Heidelberg, Germany., Brüggemann M; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig Holstein, Kiel, Germany., Dietze K; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Brauns O; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf, Aachen, Germany., Winkler T; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany., Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium, Partner Site Berlin, and German Cancer Research Center, Heidelberg, Germany., Blankenstein T; Molecular Immunology and Gene Therapy, Max Delbrück Center for Molecular Medicine, Berlin, Germany., Rosenberger L; Institute of Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Leisegang M; German Cancer Consortium, Partner Site Berlin, and German Cancer Research Center, Heidelberg, Germany.; Institute of Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL., Kammertöns T; Institute of Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Herr W; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Moosmann A; Department of Medicine III, Klinikum der Universität München, Munich, Germany.; German Center for Infection Research, Munich, Germany.; Helmholtz Munich, Munich, Germany., Strobel J; Department of Transfusion Medicine and Hemostaseology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany., Hackstein H; Department of Transfusion Medicine and Hemostaseology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany., Dornmair K; Institute of Clinical Neuroimmunology, University Hospital, Ludwig Maximilian University Munich, Munich, Germany.; Biomedical Center, Faculty of Medicine, Ludwig Maximilian University Munich, Martinsried, Germany., Beier F; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf, Aachen, Germany., Hansmann L; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium, Partner Site Berlin, and German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Publikováno v: Blood [Blood] 2024 Apr 04; Vol. 143 (14), pp. 1365-1378.
Zobrazit plný text záznamu
3
Akademický článek
HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activation.
Autor: Welters C; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin., Welters ML; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin., Stadler S; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin., Bullinger L; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin., Strobel J; Department of Transfusion Medicine and Hemostaseology, Friedrich-Alexander-University Erlangen- Nuremberg, Erlangen., Hackstein H; Department of Transfusion Medicine and Hemostaseology, Friedrich-Alexander-University Erlangen- Nuremberg, Erlangen., Dhamodaran A; T-knife Therapeutics, Inc., San Francisco, CA., Blankenstein T; Molecular Immunology and Gene Therapy, Max-Delbrück-Center for Molecular Medicine (MDC), Berlin., Hansmann L; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; Department of InternalMedicine III, University Hospital Regensburg, Regensburg. leo.hansmann@ukr.de.
Publikováno v: Haematologica [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1121-1127. Date of Electronic Publication: 2024 Apr 01.
Zobrazit plný text záznamu
4
Akademický článek
Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphoma.
Autor: Ballhausen A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany., Ben Hamza A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany., Welters C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany., Dietze K; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany., Bullinger L; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany.; German Cancer Consortium (DKTK), Berlin, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Rahn HP; Preparative Flow Cytometry, Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany., Hartmann S; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany., Hansmann ML; Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.; Institute of General Pharmacology and Toxicology, Goethe University Frankfurt, Frankfurt am Main, Germany., Hansmann L; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu, Augustenburger Platz 1, 13353, Berlin, Germany. leo.hansmann@charite.de.; German Cancer Consortium (DKTK), Berlin, Germany. leo.hansmann@charite.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. leo.hansmann@charite.de.
Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Feb; Vol. 72 (2), pp. 515-521. Date of Electronic Publication: 2022 Aug 10.
Zobrazit plný text záznamu
5
Akademický článek
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.
Autor: Welters C; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Lammoglia Cobo MF; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Stein CA; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Hsu MT; Molecular Immunology and Gene Therapy, Max-Delbrück-Center for Molecular Medicine (MDC) Berlin, Germany., Ben Hamza A; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Penter L; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Dana-Farber Cancer Institute, Boston, Massachusetts., Chen X; Molecular Immunology and Gene Therapy, Max-Delbrück-Center for Molecular Medicine (MDC) Berlin, Germany., Buccitelli C; Proteomics Platform, Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health, Berlin, Germany., Popp O; Proteomics Platform, Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health, Berlin, Germany., Mertins P; Proteomics Platform, Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health, Berlin, Germany., Dietze K; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Bullinger L; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Moosmann A; Department of Medicine III, Klinikum der Universität München, Munich, Germany.; German Center for Infection Research (DZIF), Munich, Germany., Blanc E; Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany., Beule D; Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany., Gerbitz A; Hans Messner Allogeneic Stem Cell Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada., Strobel J; Department of Transfusion Medicine and Hemostaseology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Hackstein H; Department of Transfusion Medicine and Hemostaseology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Rahn HP; Preparative Flow Cytometry, Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany., Dornmair K; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, LMU Munich, Germany., Blankenstein T; Molecular Immunology and Gene Therapy, Max-Delbrück-Center for Molecular Medicine (MDC) Berlin, Germany., Hansmann L; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v: Cancer immunology research [Cancer Immunol Res] 2022 Nov 02; Vol. 10 (11), pp. 1407-1419.
Zobrazit plný text záznamu
6
Akademický článek
Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy.
Autor: Lammoglia Cobo MF; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Welters C; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Rosenberger L; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Leisegang M; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, Illinois, USA; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Dietze K; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Pircher C; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Penter L; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gary R; Department of Internal Medicine 5-Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Takvorian A; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Moosmann A; Department of Medicine III, Klinikum der Universität München, Munich, Germany; German Center for Infection Research (DZIF), Munich, Germany., Dornmair K; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig Maximilian University of Munich, Munich, Germany., Blankenstein T; Molecular Immunology and Gene Therapy, Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany., Kammertöns T; Institute of Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Gerbitz A; Hans Messner Allogeneic Stem Cell Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada., Hansmann L; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: leo.hansmann@charite.de.
Publikováno v: Cytotherapy [Cytotherapy] 2022 Aug; Vol. 24 (8), pp. 818-826. Date of Electronic Publication: 2022 May 04.
Zobrazit plný text záznamu
7
Akademický článek
Medium- to Long-Term Outcomes after Reverse Total Shoulder Arthroplasty with a Standard Long Stem.
Autor: Bülhoff M; Clinic for Orthopaedic Surgery, Heidelberg University Hospital, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany., Zeifang F; Ethianum Clinic Heidelberg, Voßstraße 6, 69115 Heidelberg, Germany., Welters C; Clinic for Dermatology, Munich Municipal Hospital Group, Thalkirchnerstrasse 48, 80337 Munich, Germany., Renkawitz T; Clinic for Orthopaedic Surgery, Heidelberg University Hospital, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany., Schiltenwolf M; Clinic for Orthopaedic Surgery, Heidelberg University Hospital, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany., Tross AK; Clinic for Orthopaedic Surgery, Heidelberg University Hospital, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany.
Publikováno v: Journal of clinical medicine [J Clin Med] 2022 Apr 19; Vol. 11 (9). Date of Electronic Publication: 2022 Apr 19.
Zobrazit plný text záznamu
8
10-Jahres Ergebnisse nach Inverser Schulterendoprothetik
Autor: Bülhoff, M, Welters, C, Maier, MW, Zeifang, F
Publikováno v: Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2018); 20181023-20181026; Berlin; DOCST17-1237 /20181106/
Fragestellung: Fragestellung der vorliegenden Arbeit war es: Sind die klinischen und radiologischen Ergebnisse im Langzeitverlauf bei Patienten, welche mit einer Inversen Schulterprothese versorgt wurden, zufriedenstellend? Methodik: Neunundvierzig P
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a85465ed1cca48dd37535e0cb854045
Zobrazit plný text záznamu
9
Akademický článek
Comparison of Short Uncemented Metaphyseal Stem and Long-Stem Reverse Shoulder Arthroplasty in Proximal Humerus Fractures: Preliminary Study at 2-Year Follow-Up.
Autor: Ippolito, Giorgio1 (AUTHOR), Lanzetti, Riccardo Maria2 (AUTHOR) marcodoc@me.com, Ferraro, Sergio3 (AUTHOR), Pace, Valerio4 (AUTHOR), Damo, Marco1 (AUTHOR), Surace, Michele Francesco5 (AUTHOR), Giai Via, Alessio Davide Enrico2 (AUTHOR), Crivellaro, Michele6 (AUTHOR), De Marinis, Giancarlo1 (AUTHOR), Spoliti, Marco2 (AUTHOR)
Publikováno v: Journal of Clinical Medicine. Aug2024, Vol. 13 Issue 16, p4665. 11p.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje